English
Structure via PubChem · Public domain (PubChem)
thymopentin
Sign in to saveThymopentin is a thymic polypeptide derivative which interacts with T cells and acts as an immunostimulant. As such, it was used in several clinical studies in the early years of the AIDS pandemic (from 1983 to 1985). Thymopentin helped to improve immunological condition in some patients for a brief time under specific treatments. It has also been investigated more recently for applications in the treatment of rheumatoid arthritis, and lung cancer.
In the Vinony graph
Vinony's link graph records 47 inbound references to thymopentin, and connects out to peginterferon alfa-2a, HIV/AIDS and medication.
Vinony files it under Chemical pages without DrugBank identifier, Drugs with no legal status and ECHA InfoCard ID from Wikidata.
Vinony links it to 5 Wikipedia language editions.
Chemical data
- Formula
- C30H49N9O9
- Molecular weight
- 679.8 g/mol
- IUPAC name
- (3S)-3-[[(2S)-6-amino-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-4-[[(2S)-1-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid
- SMILES
- CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)N
- InChIKey
- PSWFFKRAVBDQEG-YGQNSOCVSA-N
- XLogP
- -6.4
- Polar surface area
- 328 Ų
- H-bond donors
- 11
- H-bond acceptors
- 12
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 3
- Molecule type
- Protein
- Indications
- hepatocellular carcinoma, HIV infection, neoplasm
via ChEMBL · EBI
Research
564 papers- Thymopentin and splenopentin as immunomodulators. Current status.Immunologic research · 1998
- Thymopoietin to thymopentin: experimental studies.Survey of immunologic research · 1985
- Thymopentin-integrated self-assembling nanoplatform for enhanced photo-immunotherapy in diabetic wound healing.Journal of colloid and interface science · 2025
- Thymopentin treatment of rheumatoid arthritis.Arzneimittel-Forschung · 1994
- Thymopentin in dermatology.Current problems in dermatology · 1989
via PubMed
Wikidata facts
- Mass
- 679.365
- Has use
- medication
Show 4 more facts
- chemical formula
- C₃₀H₄₉N₉O₉
- canonical SMILES
- CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)N
- isomeric SMILES
- CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)N
- subject has role
- immunologic adjuvant
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
2 sectionsContents
- See also
- References
Thymopentin is a thymic polypeptide derivative which interacts with T cells and acts as an immunostimulant. As such, it was used in several clinical studies in the early years of the AIDS pandemic (from 1983 to 1985). Thymopentin helped to improve immunological condition in some patients for a brief time under specific treatments. It has also been investigated more recently for applications in the treatment of rheumatoid arthritis, and lung cancer.
== See also == Thymopoietin
Excerpted from Wikipedia’s “thymopentin” article, available under the CC BY-SA 4.0 licence.